Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024

Published on July 17, 2024

ENGLEWOOD, Colo., July 17, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company’s management will webcast a corresponding conference call beginning at …

The post Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024 appeared first on Ortho Spine News.

Continue reading on website
Other news

HSS Appoints Constantine A. Demetracopoulos, MD, Chief of Foot and Ankle Service

July 17, 2024
NEW YORK, July 17, 2024 /PRNewswire/ — Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, today announced the appointment of Constantine A. Demetracopoulos, MD, as chief of the Foot and Ankle Service. Dr. Demetracopoulos will succeed Matthew M. Roberts, MD, who has led the Foot and Ankle Service since 2013. Dr. Roberts will continue h

Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

July 19, 2024
AUDUBON, Pa., July 18, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) application. This new robotic navigation platform joins the already best-in-class Excelsius™ ecosystem, designed to of